Ap. Feranchak et al., Fulminant Epstein-Barr viral hepatitis: Orthotopic liver transplantation and review of the literature, LIVER TR S, 4(6), 1998, pp. 469-476
Acute hepatic failure caused by primary Epstein-Barr virus (EBV) infection
has been reported in the literature in 16 cases, with an overall mortality
of 87%. We report a case of fulminant hepatic failure in an immunocompetent
young girl caused by primary EBV infection that was treated by orthotopic
liver transplantation. After transplantation she has been treated with low-
dose immunosuppression, a pooled gammaglobulin preparation containing anti-
EBV antibodies, and anti-viral therapy. The patient is presently doing well
2 years after transplantation without evidence of clinical EBV infection,
primary immunodeficiency, or lymphoproliferative disease. (C) 1998 by the A
merican Association for the Study of Liver Diseases.